GlaxoSmithKline recalls the prescription heartburn medicine Zantac in all markets as a precaution days after the U.S. Food and Drug Administration finds 'unacceptable' levels of a probable cancer-causing impurity in the drug.
Heartburn drug Zantac recalled as a 'precaution'
Post a Comment